Is COVID-19-associated cytokine storm distinct from non-COVID-19 secondary hemophagocytic lymphohistiocytosis? [PDF]
Exp Biol Med (Maywood), 2022 Liu JM, Chi J.
europepmc +1 more source
From joints to vessels: How rheumatoid arthritis therapy alters the fate of the heart. [PDF]
World J CardiolZotova LA, Enenkov NV.
europepmc +1 more source
Cytokines and Chemokines in SARS-CoV-2 Infections-Therapeutic Strategies Targeting Cytokine Storm. [PDF]
Biomolecules, 2021 Pum A, Ennemoser M, Adage T, Kungl AJ.
europepmc +1 more source
Molecular signaling pathways, pathophysiological features in various organs, and treatment strategies in SARS-CoV2 infection. [PDF]
Acta Histochem, 2022 Rasmi Y +7 more
europepmc +1 more source
Are the Goals of Therapy Achievable in Patients with Rheumatoid Arthritis Receiving Upadacitinib in Real Clinical Practice? [PDF]
Dokl Biochem Biophys, 2023 Amirdzhanova VN +11 more
europepmc +1 more source
Interstitial inflammation and pulmonary fibrosis in COVID-19: The potential role of cytostatic therapy for severe lung injury. [PDF]
Respir Med Case Rep, 2022 Filimonova EV +3 more
europepmc +1 more source
Interleukin-6, CXCL10 and Infiltrating Macrophages in COVID-19-Related Cytokine Storm: Not One for All But All for One! [PDF]
Front Immunol, 2021 Coperchini F, Chiovato L, Rotondi M.
europepmc +1 more source
Targeting interleukin-6 as a treatment approach for peritoneal carcinomatosis. [PDF]
J Transl MedDadgar N +11 more
europepmc +1 more source
Novel therapeutic targets for metabolism-related diseases: proteomic Mendelian randomization and colocalization analyses. [PDF]
Ther Adv Endocrinol MetabZhang YY, Wang BL, Chen BX, Wan Q.
europepmc +1 more source